MET Stock Analysis: Buy, Sell, or Hold?
MET - MetLife, Inc.
$71.17
0.45 (0.64%)
▲
5d:
+1.11%
30d:
-2.06%
90d:
-10.79%
BUY
HIGH Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: Apr 29, 2026
26d
Smart Money Accumulation
MET is down 4.8% this week, but smart money is accumulating calls. Top strike: $80 2026-04-17 with 1,289 OI. Call ratio: 61% View Scanner →
Strength: 3.4/10
Get Alerted When MET Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: MET trading at deep discount. Market pricing in -3.9% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: MET trading at deep discount. Market pricing in -3.9% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$116.34
Based on 7.9% avg growth
INTRINSIC VALUE TODAY
$72.24
1.5% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: MET is currently trading at $71.17, which is considered fair relative to its 30-day fair value range of $68.56 to $73.38. From a valuation perspective, the stock is trading at a discount (Forward PE: 6.5) compared to its historical average (7.3). Remarkably, the market is currently pricing in an annual earnings decline of 3.9% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, MET is in a strong downtrend. The price is approaching resistance at $72.12. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: MET has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $90.50 (+27.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MET is in a strong downtrend. The price is approaching resistance at $72.12. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: MET has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $90.50 (+27.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$68.56 -
$73.38
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
83.3%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 27.2% below Wall St target ($90.50)
Fair Price Analysis
30-Day Fair Range
$68.56 -
$73.38
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$67.33
Resistance Level
$72.13
Current Trend
Strong Downtrend
Technical data as of
Apr 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
6.51
Wall Street Target
$90.50
(+27.2%)
Revenue Growth (YoY)
27.6%
Earnings Growth (YoY)
-34.2%
Profit Margin
4.4%
Valuation Discount vs History
-3.9% cheaper
PE vs Historical
6.5 vs 7.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.9%
(market-implied from PE analysis)
1-Year Target
$68.39
(-4%)
2-Year Target
$65.73
(-8%)
3-Year Target
$63.16
(-11%)
3-Yr Target (if PE normalizes)
(PE: 7→7)
$70.87
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 11.7%)
$340.72
(+379%)
Base:
(SPY PE: 6.5, Growth: 11.7%)
$99.18
(+39%)
Bear:
(PE: 5.5, Growth: 11.7%)
$84.30
(+19%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (15x PE), but valuation improves significantly next year (7x PE) as earnings recover.
Trailing PE: 14.56 | Current EPS (TTM): $4.71
Bull Case
$150.83
(+118%)
Analyst growth 100.0%, PE expands to 16.0
Base Case
$137.12
(+98%)
Market implied 100.0%, PE stable at 14.6
Bear Case
$46.62
(-33%)
Severe decline -20.0%, PE contracts to 12.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 6.5 to 7.3
Stabilization Target:
$79.86
(+12.2%)
PE Expansion Potential:
+12.2%
Share & Embed Analysis
Last updated: April 02, 2026 7:24 AM ET
Data refreshes hourly during market hours. Next update: 8:24 AM
Data refreshes hourly during market hours. Next update: 8:24 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MET showing a specific setup today?
Insider Activity (6 Months)
4
Buys
3
Sells
+
Net
NEUTRAL
Recent Transactions
Ro Khanna
BUY
2026-02-24
Ro Khanna
SELL
2026-01-29
Ro Khanna
SELL
2026-01-22
Top Rated Insurance - Life Stocks
Top-rated stocks in Insurance - Life by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
UNM
Unum Group |
BUY
12 analysts |
$93 | 60 BUY |
|
MFC
Manulife Financial Corp |
BUY
13 analysts |
$34 | 59 HOLD |
|
ABL
Abacus Life Inc. |
STRONG BUY
5 analysts |
$14 | 58 HOLD |
|
GL
Globe Life Inc |
BUY
10 analysts |
$172 | 65 BUY |
|
PRU
Prudential Financial Inc |
SELL
16 analysts |
$110 | 65 BUY |
Advanced MET Option Strategies
Professional options setups generated by AI based on today's MET price and gamma walls.
